Evidence map›Paper›PMID 42571225›Full record

ArticleBlood neoplasia2026

Evaluating response criteria in myelodysplastic/myeloproliferative neoplasms: a systematic review and meta-analysis.

Anthony M Hunter, Somedeb Ball, Rena Buckstein, Catherine Cargo, Melissa Fischer, Devendra Hiwase, Raphael Itzykson, Sanam Loghavi, Luca Malcovati, Moshe Mittelman and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood neoplasia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Anthony M HunterDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.
Somedeb BallDivision of Hematology and Oncology, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN.
Rena BucksteinOdette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Catherine CargoHaematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, United Kingdom.
Melissa FischerMyelodysplastic Syndrome/MPN International Working Group, Smyrna, TN.
Devendra HiwaseSouth Australian Health and Medical Research Institute, Adelaide, Australia.
Raphael ItzyksonUniversité Paris Cité, INSERM, Centre National de la Recherche Scientifique, Institut de Recherche Saint Louis, Paris, France.
Sanam LoghaviDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Luca MalcovatiUnit of Molecular Hematology and Precision Medicine, University of Pavia and Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo, Pavia, Italy.
Moshe MittelmanTel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.
Eric PadronDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
Mrinal M PatnaikDivision of Hematology, Mayo Clinic, Rochester, MN.
Valeria SantiniMyelodysplastic Syndrome Unit, Hematology, Dipartimento di Medicina Sperimentale e Clinica University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Daniel ThomasSouth Australian Health and Medical Research Institute, Adelaide, Australia.
Arjan A Van de LoosdrechtDepartment of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Daniel H WisemanEpigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.
Blanca XicoyClinical Hematology Department-Institut Català d' Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
Michael R SavonaDivision of Hematology and Oncology, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN.
Douglas TremblayDivision of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42571225
PMCPMC13451810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.